PharmaCyte Biotech, Inc. (PMCB)
Current price: $0.58
These defaults work well for most companies. Only adjust them if you have a specific view on this business's risk profile or long-term growth prospects.
Graham Number
√(22.5 × EPS × Book Value per Share)
$23.41
+3964% upside
Earnings Power Value
Normalized after-tax earnings ÷ required return (zero-growth)
Not applicable
Median operating income over the available period is negative — not generating operating earnings on a normalized basis.
DCF Fair Value
Projected free cash flow discounted to present value + terminal value
Not applicable
Insufficient history: requires at least 3 years of free cash flow (found 0).
P/E Fair Value
Earnings per share × target P/E multiple
$47.85
+8207% upside
Valuation estimates are models, not investment advice. They are highly sensitive to the assumptions chosen and carry significant uncertainty. Past fundamentals do not guarantee future performance.